Candesartan dosage forms and strengths

Revision as of 02:27, 20 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Candesartan}} {{CMG}}; {{AE}} {{SS}} ==Dosage Forms and Strengths== 4 mg are white to off-white, circular/biconvex-shaped, non-film-coated scored tablets, coded A...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Candesartan
ATACAND® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Candesartan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Dosage Forms and Strengths

4 mg are white to off-white, circular/biconvex-shaped, non-film-coated scored tablets, coded ACF on one side and 004 on the other.

8 mg are light pink, circular/biconvex-shaped, non-film-coated scored tablets, coded ACG on one side and 008 on the other.

16 mg are pink, circular/biconvex-shaped, non-film-coated scored tablets, coded ACH on one side and 016 on the other.

32 mg are pink, circular/biconvex-shaped, non-film-coated scored tablets, coded ACL on one side and 032 on the other.[1]


References

  1. "ATACAND (CANDESARTAN CILEXETIL) TABLET [ASTRAZENECA LP]". Retrieved 20 February 2014.

Template:Angiotensin II receptor antagonists